N61S (p.Asn61Ser) variant of LPA (Apolipoprotein(a))

N61S (p.Asn61Ser) in LPA (Apolipoprotein(a)) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.08 / 1. The record also includes population frequency data and structural context.

N61S (p.Asn61Ser) variant details